2018台灣生技月 Bio Taiwan 生物科技大展

2018 台灣生技月 南港展覽館

PROGRAM

BioBusiness Asia Conference 2017

(You can see more information by click on Session Title/Speaker title/Speaker's name)

June 28 (Wednesday)

Venue: 3F, Bldg. A, CTBC Financial Park

BioBusiness Asia Conference

08:30 – 09:00

Registration

BBA Plenary Session –Trends Shaping the Global Biotech Landscape

Ballroom A

09:00 – 09:05

Welcoming Remarks
Johnsee Lee, Chairman, Taiwan Bio Industry Organization

09:05 – 09:15

Opening Remarks
Government Representative

09:15 – 09:45

Biotechnology Financing and Deal-Making State of the Industry
Patrick Flochel, Global Pharmaceutical Life Science Leader, Ernst & Young

09:45 – 10:15

Building a Successful Global Medical Device Business 
Yuh-geng Tsay, Venture Partner, VIVO Capital; Former Group President, Thermo Fisher

10:15 – 10:35

Break

10:35 – 11:05

Next-Generation Therapeutic Platforms
Timothy Lu, Associate Professor, MIT


11:05 – 11:35
 
Biosimilar Market Overview
Allen Y. Chao, Founding CEO of Watson Pharmaceuticals; CEO of Tanvex BioPharma

11:35 – 12:15

Panel Discussion
Moderator: Johnsee Lee
Panelists: Patrick Flochel, Yuh-geng Tsay, Timothy K. Lu, Allen Y. Chao 
                James Cai, VP of Regulatory Affairs, Japan Asia Pacific, Amgen 

Luncheon – Fighting Infectious Diseases

Ballroom A

12:25 – 12:30 Opening Remarks
Session Chair: Stanley Chang, Chairman & CEO, Medigen Biotechnology Corp.
12:30 – 12:50 New Vaccine Development Strategy: Using Sanofi Pasteur as an Example
Alain Bouckenooghe, Associate VP and Regional Head of Clinical R&D Sanofi Pasteur, Asia Pacific
12:50 – 13:10 Fighting bacterial resistance and HCV infections
Ming-Chu Hsu, Chairman & CEO, TaiGen Biotechnology
13:10 – 13:30 Specific Immunotherapy (SIT) Another Step in Precision Medicine
Frank L. Douglas, Chief Executive Officer, USA, TheVax Genetics Vaccine Co. Ltd.
13:30 – 13:45 Fighting the Most Neglected Tropical Disease – Dengue
Meei-Yun Lin, Immunologist, Medigen Vaccine Biologics Corp.
13:45 – 14:05 Panel Discussion
Moderator: Stanley Chang, Chairman & CEO, Medigen Biotechnology Corp.
Panelists: Alain Bouckenooghe, Ming-Chu Hsu, Frank L. Douglas, Meei-Yun Lin
 

June 28 (Wednesday)

Venue: 3F, Bldg. A, CTBC Financial Park

BBA Session 1 – Building a Biologics Industry for Tomorrow's Challenges

Ballroom A

14:10 – 14:15

Opening Remarks
Session Chair: Karen Wen, President, Mycenax

14:15 – 14:40

Strategic Decisions on Developing Biosimilars
James Cai, VP of Regulatory Affairs, Japan Asia Pacific, Amgen

14:40 – 15:05

Innovative Technologies for Cell Banking and Biosafety Testing
Christophe Valat, International Development Director, Texcell

15:05 – 15:30

How to Assess Analytical Similarity for a Potential Biosimilar Product
Jennifer Liu, Director, Analytical Sciences, Biosimilars Process Development, Amgen

15:30 – 16:05

Panel Discussion
Moderator: Karen Wen, President, Mycenax
Panelists: James Cai, Christophe Valat, Jennifer Liu

16:05 – 16:20

Break

BBA Session 2 – Next Generation Sequencing & its Impact

Ballroom B

14:10 – 14:15

Opening Remarks
Johnsee Lee, Chairman, Taiwan Bio Industry Organization

14:15 – 14:40

Applications of Next Generation Sequencing for Precision Cancer Management
Shu-Jen Chen, CSO, ACT Genomics

14:40 – 15:05

"Project Oxygen" in the Precision Medicine Era – Application and Impact of NGS
Pei-Li Li, Vice President, Genetics Generation Advancement Corp.

15:05 – 15:30

The New Age of Spatial Sequencing
Shawn Marcell, Chairman & CEO, ReadCoor

15:30 – 16:05

Panel Discussion
Moderator: Johnsee Lee, Chairman, Taiwan Bio Industry Organization
Panelists: Shu-Jen Chen, Pei-Li Li, Shawn Marcell
                Carl Firth, CEO, ASLAN Pharmaceuticals

16:05 – 16:20

Break

BBA Session 3 – Investment Strategies for Biotech's New Paradigm

Ballroom B

16:20 – 16:25

Opening Remarks
Session Chair: Audrey Tseng, Deputy Chairman, PwC Taiwan

16:25 – 16:45

Global Healthcare Industry Development Trend and Vivo Ventures Fund's Investment Strategy
Jo Shen, Venture Partner, Vivo Capital

16:45 – 17:05

Emerging Healthcare Markets and KPCB's Investment Strategy
James Huang, Managing Partner, Kleiner Perkins Caufield & Byers China

17:05 – 17:25

Alliances to Drive Biomedical Innovation: An Overview of Pfizer R&D Partnering Strategy and Asia Initiatives
Toru J Seo, Head, Pfizer External Science and Innovation Japan, Worldwide Research & Development, Pfizer Inc.

17:25 – 17:45

Innovation Trend and DCIP’s Investment Strategy Across Taiwan and Japan
Kodama Shuntaro, Managing Director, DCI Partners

17:45 – 18:20

Panel Discussion - Taiwan’s Biotech Opportunities and Challenges
Moderator: Hung-Jen Chang, Chairman and CEO YFY Biotech Management Company
Panelists: Jo Shen, James Huang, Toru J Seo, Kodama Shuntaro

 

June 28 (Wednesday)

Venue: 3F, Bldg. A, CTBC Financial Park

14:00 – 18:00

Company Presentations

Ballroom C 

 

June 28 (Wednesday)

Venue: 3F, Bldg. A, CTBC Financial Park

18:30 – 21:00

BioTaiwan 2017 Banquet

Ballroom A 

 

June 29 (Thursday)

Venue: 3F, Bldg. A, CTBC Financial Park

08:30 – 09:00

Registration

BBA Session 4 - The Future of Medical Technology in the Digital Age

Ballroom A

09:00 – 09:10

Opening Remarks
Session Chair: Chii-Wann Lin, Vice President and General Director Biomedical Technology and Device Research Laboratories, ITRI

09:10 – 09:40

The Prospect of Medical Technologies
Peter Fitzgerald, Professor Emeritus of Stanford University, Managing Partner and Co-Founder of TransPacific VC (Taipei) and Triventures (Israel)

09:40 – 10:15

How will Biomedical Development Board (BDB) of Taiwan Drive Medtech Innovation and Growth
Chris Fang, Co-Chairman, Biomedical Development Board of Taiwan; Managing Partner, Amaris Capital

10:15 – 10:30

Coffee Break

10:30 – 11:05

Hospitals and Digital Health: Roles and Responsibilities in Healthcare Reform
Jimmy Ming-Yuan Huang, Digital Health Consultant, MacKay Memorial Hospital

11:05 – 11:55

Panel Discussion
Moderator: Chii-Wann Lin, Vice President and General Director Biomedical Technology and Device Research Laboratories, ITRI
Panelists: Peter Fitzgerald, Jane Liu, Jimmy Ming-Yuan Huang,

BBA Session 5 - The Impact of Advances in Emerging Healthcare Technologies

Ballroom B

09:00 – 09:10

Opening Remarks
Session Chair:  Timothy Lu, Associate Professor, MIT

09:10 – 09:45

What Happens After the Last Antibiotic Fails?
Christina Tsai, Chief Science Officer & Co-founder, EpiBiome

09:45 – 10:20

Engineered Microbiome Therapies
Timothy Lu, Associate Professor, MIT

10:20 – 10:35

Coffee Break

10:35 – 11:10

Cell and Gene Therapy: A Promising, but Challenging New Horizon for Healthcare
William Milligan, SVP CD & BD, Steminent Biotherapeutics

11:10 – 12:00

Panel Discussion
Moderator: Timothy Lu
Panelists: Christina Tsai, William Milligan
                Alex Zhavoronkov, Co-founder & CEO, Insilico Medicine
                Andrea de Souza, Global Business Development, NVIDIA, AI for Healthcare

 

June 29 (Thursday)

Venue: 3F, Bldg. A, CTBC Financial Park

BioBusiness Asia Conference

Luncheon – Sharing the Experience of Biotech Success

Ballroom A

12:00 – 12:15 Registration
12:15 – 12:20 Welcome Remarks
Johnsee Lee, Chairman, Taiwan Bio Industry Organization
12:20 – 12:30 Opening Remarks
Government Representative (Inviting)
12:30 – 13:50 Sharing the Experience of Biotech Success
Session Chair:Johnsee Lee
 
2017 Taiwan Bio Industry Organization Award-Outstanding Company of the Year
TCI Co., Ltd. (Yung-Hsiang Lin, Chairman, TCI Co., Ltd.)
 
2017 Taiwan Bio Industry Organization Award -Emerging Company of the Year
United BioPharma, Inc. (Mei-June Liao, President, United BioPharma, Inc.)
EirGenix, Inc. (You-Nan Shih, Senior Vice President, Quality & EHS, EirGenix, Inc.)
 
2017 Taiwan Bio Industry Organization Award - Innovation of the Year
TaiGen Biotechnology (Chih-Ming Chen, Director, Antiviral Research, TaiGen Biotechnology)
MagQu Co., Ltd. (Shieh-Yueh Yang, CEO, MagQu Co., Ltd.)
 
Discussion and Q&A
BBA Session 6 - Increasing the Odds: The Promise of the Precision Oncology Revolution Ballroom A

14:00 – 14:05

Welcome & Opening Remarks
Lawrence L. Gan, President, Development Center for Biotechnology (DCB)

14:05 – 14:10

Guest of Honor Speech
Dr. Eugene Lin, Science and Technology Advisor, DoIT, MOEA

14:10– 14:40

Artificial Intelligence for Anti-Cancer Drug Discovery
Dr. Alex Zhavoronkov, Co-founder and Chief Executive Officer, InSilico Medicine

14:40 – 15:10

Unlock the Potential of Precision Medicine Using Deep Learning
Andrea de Souza, Global Business Development, NVIDIA, AI for Healthcare

15:10 – 15:40

Panel Discussion: Utilizing ICT for Precision Medicine
Moderator: Ting-Shou Chen, Division Director Planning and Marketing Division, ITRI BDL
Panelists: Dr. John Connolly, Chief Scientific Officer, Tessa Therapeutics
                Dr. Alex Zhavoronkov, Co-founder and Chief Executive Officer, Insilico Medicine
                Andrea de Souza, Global Business Development, NVIDIA, AI for Healthcare

15:40 – 16:05 Guest of Honor Remarks & Letter of Intent Signing Ceremony
16:05 – 16:20 Coffee Break

16:20 – 16:50

Big Data Meets Cancer Immunotherapy
Dr. John Connolly, Chief Scientific Officer, Tessa Therapeutics

16:50 – 17:20

ERY974: A First-in-class T Cell-redirecting Bispecific Antibody Targeting Glypican-3
Dr. Junichi Nezu, Senior Specialist, Chugai Pharmaceutical Co., Ltd.

17:20 – 17:50

INDs, Marketing Applications and Lifecycle Maintenance for Oncology Products
Lana Pauls, Director, Global Regulatory Affairs, North America, Quintiles

17:50 – 18:20

Panel Discussion: Precision Oncology: Technology, Regulations, and Challenges
Moderator: Chao-Pin Lee, Vice President, Development Center for Biotechnology
Panelists: Dr. Junichi Nezu, Research Head, Chugai Pharmabody Research
                Lana Pauls, Director, Global Regulatory Affairs, North America, Quintiles

 

June 29 (Thursday)

Venue: 3F, Bldg. A, CTBC Financial Park

BioBusiness Asia Conference

BBA Session 7 - Niche Biotech: Utilizing Regional Strengths for Global Competitiveness

Ballroom B

14:00 – 14:05

Opening Remarks
Session Chair: Wendy Huang, President & CEO, Lumosa Therapeutics

14:05 – 14:35

"reSearch & Development": Science is the Core, Focus is the Essence
Wendy Huang, President & CEO, Lumosa Therapeutics

14:35 – 15:05

Re-Purposing and Drug Delivery: A Springboard to Global New Drug Business
Larry Hsu, Chairman & CEO, Lifemax Healthcare International Corporation 

15:05 – 15:35

Building an "Old School" Biotech Company to Discover Novel Biological Medicines
Hui Tian, VP Research, NGM Biopharmaceuticals, Inc.

15:35 – 16:05

Panel Discussion
Moderator: Wendy Huang
Panelists: Larry Hsu, Hui Tian

16:05 – 16:20

Coffee Break

BBA Session 8 - M&A Strategies for Achieving Next Level Growth

Ballroom B

16:20 – 16:25

Opening Remarks
Session Chair: CY Huang, Founding Chairman, Taiwan Mergers & Acquisitions and Private Equity Council

16:25 – 17:05

M&A Trends in the Asia-Pasific Life Science Industry
Christian Boettcher, Director, Deloitte Tohmatsu Consulting LLC (Japan)

17:05 – 17:40

The ABCs of Collaborating with Big Pharma:  M&A, JV, Options, Licenses, SRAs, and ROFRs
Erin Ator Thomson, Counsel, Intellectual Property Counseling, Vinson & Elkins LLP

17:40 – 18:15

Panel Discussion
Moderator: CY Huang
Panelists: Christian Boettcher, Erin Ator Thomson,
Yuh-geng Tsay, Venture Partner, VIVO Capital

 

June 29 (Thursday)

Venue: 3F, Bldg. A, CTBC Financial Park

09:40 – 18:00

Company Presentations

Ballroom C